MWPCG
GILD icon

Measured Wealth Private Client Group’s Gilead Sciences GILD Stock Holding History

Measured Wealth Private Client Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Hold
2,072
– – 0.06% 170
2026
Q1 		$289K Hold
2,072
– – 0.08% 146
2025
Q4 		$254K Hold
2,072
– – 0.07% 158
2025
Q3 		$230K Hold
2,072
– – 0.06% 161
2025
Q2 		$230K Sell
2,072
-11
-0.5% -$1.17K 0.07% 165
2025
Q1 		$233K Sell
2,083
-230
-10% -$23.7K 0.07% 154
2024
Q4 		$214K Sell
2,313
-137
-6% -$12.3K 0.07% 167
2024
Q3 		$205K Buy
+2,450
New +$187K 0.07% 172
2024
Q2 		– Sell
-4,977
Closed -$365K – 197
2024
Q1 		$365K Sell
4,977
-585
-11% -$45K 0.13% 122
2023
Q4 		$451K Sell
5,562
-8,369
-60% -$651K 0.17% 106
2023
Q3 		$1.04M Buy
13,931
+1,478
+12% +$114K 0.42% 34
2023
Q2 		$960K Buy
12,453
+1,923
+18% +$153K 0.36% 36
2023
Q1 		$874K Buy
10,530
+1,855
+21% +$154K 0.34% 40
2022
Q4 		$745K Buy
8,675
+3,864
+80% +$306K 0.31% 45
2022
Q3 		$297K Buy
+4,811
New +$303K 0.13% 105
2018
Q4 		– Sell
-1,216
Closed -$95K – 334
2018
Q3 		$95K Buy
+1,216
New +$91.8K 0.06% 240

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Measured Wealth Private Client Group's GILD Position: Q2 2026 in Review

Measured Wealth Private Client Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,072 shares worth $262K. The position accounts for 0.06% of the portfolio, ranked #170.

Measured Wealth Private Client Group first reported a position in GILD in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.04M in Q3 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Measured Wealth Private Client Group held 2,072 shares of Gilead Sciences worth $262K as of Q2 2026.
  • Measured Wealth Private Client Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.06% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #170 holding.
  • Measured Wealth Private Client Group first reported a position in Gilead Sciences in Q3 2018 and has held it in 16 quarters since.
  • Measured Wealth Private Client Group's Gilead Sciences position peaked at $1.04M in Q3 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.